Literature DB >> 27827463

Tumor cell proliferation, proliferative index and mitotic count in lung cancer.

Lucian R Chirieac1.   

Abstract

Entities:  

Year:  2016        PMID： 27827463      PMCID： PMC5099513          DOI： 10.21037/tlcr.2016.10.10

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  21 in total

1.  Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact.

Authors:  Deniz L Aslan; H Evin Gulbahce; Stefan E Pambuccian; J Carlos Manivel; Jose Jessurun
Journal:  Am J Clin Pathol       Date:  2005-06       Impact factor: 2.493

2.  Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis.

Authors:  Z K Arbiser; J L Arbiser; C Cohen; A A Gal
Journal:  Mod Pathol       Date:  2001-12       Impact factor: 7.842

3.  Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach.

Authors:  Tina Zahel; Sabine Krysa; Esther Herpel; Albrecht Stenzinger; Benjamin Goeppert; Peter Schirmacher; Hans Hoffmann; Philipp A Schnabel; Arne Warth
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

4.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Authors:  Kyuichi Kadota; Kei Suzuki; Stefan S Kachala; Emily C Zabor; Camelia S Sima; Andre L Moreira; Akihiko Yoshizawa; Gregory J Riely; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Mod Pathol       Date:  2012-04-13       Impact factor: 7.842

Review 5.  Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.

Authors:  Giuseppe Pelosi; Mauro Papotti; Guido Rindi; Aldo Scarpa
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

Review 6.  Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.

Authors:  Giuseppe Pelosi; Guido Rindi; William D Travis; Mauro Papotti
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

7.  Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Authors:  G Rindi; C Klersy; F Inzani; G Fellegara; L Ampollini; A Ardizzoni; N Campanini; P Carbognani; T M De Pas; D Galetta; P L Granone; L Righi; M Rusca; L Spaggiari; M Tiseo; G Viale; M Volante; M Papotti; G Pelosi
Journal:  Endocr Relat Cancer       Date:  2013-12-16       Impact factor: 5.678

8.  ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.

Authors:  Birgit Guldhammer Skov; Bente Holm; Anders Erreboe; Torsten Skov; Anders Mellemgaard
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

9.  Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score.

Authors:  Franco Grimaldi; Daniele Muser; Carlo Alberto Beltrami; Piernicola Machin; Angelo Morelli; Stefano Pizzolitto; Giovanni Talmassons; Francesca Marciello; Annamaria Anita Livia Colao; Roberto Monaco; Guglielmo Monaco; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2011-08-19       Impact factor: 5.555

10.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; C Mascaux; T Berghmans; P Lothaire; A-P Meert; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640
View more
  1 in total

1.  Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67.

Authors:  Karthika P Padmavathy; Veena Kumari Vuttaradhi; Akkanapally Venu; Lawrence D'Cruze; Roshni Saravanan; Ravishankar Pitani; Krishnamurthy Ganesh; Himavani Pacharla; Suresh Kumar Rayala; D Prathiba; Ganesh Venkatraman
Journal:  J Mol Neurosci       Date:  2020-09-22       Impact factor: 3.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.